Tumour-informed liquid biopsies to monitor advanced melanoma patients under immune checkpoint inhibition

Abstract Immune checkpoint inhibitors (ICI) have significantly improved overall survival in melanoma patients. However, 60% experience severe adverse events and early response markers are lacking. Circulating tumour DNA (ctDNA) is a promising biomarker for treatment-response and recurrence detection...

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	Nature Communications
المؤلفون الرئيسيون:	Christopher Schroeder, Sergios Gatidis, Olga Kelemen, Leon Schütz, Irina Bonzheim, Francesc Muyas, Peter Martus, Jakob Admard, Sorin Armeanu-Ebinger, Brigitte Gückel, Thomas Küstner, Claus Garbe, Lukas Flatz, Christina Pfannenberg, Stephan Ossowski, Andrea Forschner
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Nature Portfolio 2024-10-01
الوصول للمادة أونلاين:	https://doi.org/10.1038/s41467-024-52923-0